[PDF] from stemcellres.comEJ Gudgin… - Stem Cell Research & Therapy, 2011 - Springer To date, cytogenetic abnormalities have provided most prognostic information, although up to 50% of patients have a normal karyotype [2]. In addition, over the past decade the detection of specific molecular mutations, including mutations in the NPM1 and FLT-3 genes, have ... Related articles - All 4 versions
[PDF] from peerproject.euC Sotiriou, C Desmedt, S Michiels, B Haibe-Kains… - 2011 - repository.peerproject.eu Page 1. Time to move forward from “first generation” prognostic gene signatures ... are at high or low risk of cancer recurrence, such as MammaPrint [3], the Oncotype Dx [4] and the Gene Expression Grade Index [5]. The prognostic value of these 3 scores have all ...
A Rossi, FL Dini, P Faggiano, M Cicoira, S Frattini… - Heart, 2011 - heart.bmj.com Methods and results Patients with HF due to ischaemic and non-ischaemic dilated cardiomyopathy (DCM) were retrospectively recruited. The clinical end point was a composite of all-cause mortality and hospitalisation for worsening HF. FMR was quantitatively determined by measuring ...
LG Mellbin, K Malmberg, A Norhammar, H Wedel… - Diabetologia, 2011 - Springer Abstract Aims/hypothesis This post hoc analysis from the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 trial reports on extended long-term outcome in relation to glucose-lowering agents in patients with myocardial infarction and type 2 diabetes. ... Related articles - All 3 versions
B Chibaudel, F Bonnetain, C Tournigand… - The …, 2011 - AlphaMed Press The content of this article has been reviewed by independent peer reviewers to ensure that it is balanced, objective, and free from commercial bias. No financial relationships relevant to the content of this article have been disclosed by the independent peer reviewers.